FDA approves ozanimod for relapsing and secondary progressive forms of MSMarch 26, 2020Multiple Sclerosis
N-acetyl cysteine may positively affect cerebral glucose metabolism in MSMarch 19, 2020Multiple Sclerosis
Vitamin D levels tied to clinical and radiological outcomes in early relapsing MSMarch 19, 2020Multiple Sclerosis
Multidisciplinary rehabilitation can improve highly impacting symptoms of relapse-onset MSMarch 19, 2020Multiple Sclerosis
60% of morbidity comes from 30% of patients with moderate-to-severe MSMarch 19, 2020Multiple Sclerosis
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MSMarch 12, 2020Multiple Sclerosis
